Incremental Cost Of Brain Metastases Among Patients With Metastatic Melanoma

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Targeting Brain Metastases in Patients with Melanoma

Patients with brain metastases from malignant melanoma historically have a very poor outcome. Surgery and radiotherapy can be used, but for the majority of patients the disease will progress quickly. In the recent past, patients with brain metastases derived only minimal benefit from cytotoxic chemotherapy. Novel therapies that have been shown to be superior to chemotherapy in metastatic melano...

متن کامل

Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma

A 53year-old woman was admitted with chief complaints of progressive dyspnea, numbness, and paresthesia of the right side which had lasted for one month. Four years earlier, her right big toe had amputated due a diagnosis of acral lentiginous melanoma. She had had no problems for three years but then developed cervical lymphadenopathy. Excisional biopsy revealed metastatic melanoma. She also ha...

متن کامل

ZOSTERIFORM METASTASES IN A MAN WITH MALIGNANT MELANOMA

Zosteriform metastasis is a rare clinical distribution from spreading neoplasms of every organ to the skin. Tumors most often arise from a n internal o r hematologic malignancy. W e report a 69-year-old man, a known case of malignant melanoma of the left heel. In this case, multiple red-brown metastatic nodules appeared four months after diagnosis. Distribution of metastatic lesions resemb...

متن کامل

Long-term survivors among breast cancer patients with brain metastases.

We read the article by Niwinska et al. [1] in which they carried out a comprehensive analysis of 222 consecutive patients with breast cancer and brain metastases. They found that median survival from brain metastases in recursive partitioning analysis Radiation Therapy Oncology Group prognostic class I, II and III were 15, 11 and 3 months, respectively. A recent retrospective study evaluated cl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2013

ISSN: 1098-3015

DOI: 10.1016/j.jval.2013.03.674